Strides Pharma Science Limited

BSE:532531 Stock Report

Market Cap: ₹86.2b

Strides Pharma Science Management

Management criteria checks 1/4

Strides Pharma Science's CEO is Badree Komandur, appointed in Jun 2024, has a tenure of 1.42 years. total yearly compensation is ₹58.10M, comprised of 74.9% salary and 25.1% bonuses, including company stock and options. directly owns 0.06% of the company’s shares, worth ₹51.41M. The average tenure of the management team and the board of directors is 1.4 years and 7.2 years respectively.

Key information

Badree Komandur

Chief executive officer

₹58.1m

Total compensation

CEO salary percentage74.87%
CEO tenure1.4yrs
CEO ownership0.06%
Management average tenure1.4yrs
Board average tenure7.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Badree Komandur's remuneration changed compared to Strides Pharma Science's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

₹4b

Jun 30 2025n/an/a

₹3b

Mar 31 2025₹58m₹44m

₹4b

Dec 31 2024n/an/a

₹3b

Sep 30 2024n/an/a

₹2b

Jun 30 2024n/an/a

-₹475m

Mar 31 2024₹44m₹37m

-₹1b

Dec 31 2023n/an/a

-₹2b

Sep 30 2023n/an/a

-₹2b

Jun 30 2023n/an/a

-₹924m

Mar 31 2023₹44m₹36m

-₹2b

Dec 31 2022n/an/a

-₹2b

Sep 30 2022n/an/a

-₹2b

Jun 30 2022n/an/a

-₹4b

Mar 31 2022₹46m₹38m

-₹5b

Dec 31 2021n/an/a

-₹4b

Sep 30 2021n/an/a

-₹3b

Jun 30 2021n/an/a

-₹543m

Mar 31 2021₹44m₹33m

₹3b

Dec 31 2020n/an/a

₹28m

Sep 30 2020n/an/a

₹589m

Jun 30 2020n/an/a

₹1b

Mar 31 2020₹37m₹23m

₹492m

Dec 31 2019n/an/a

₹3b

Sep 30 2019n/an/a

₹2b

Jun 30 2019n/an/a

₹745m

Mar 31 2019₹32m₹18m

₹840m

Compensation vs Market: Badree's total compensation ($USD654.61K) is above average for companies of similar size in the Indian market ($USD399.98K).

Compensation vs Earnings: Badree's compensation has increased by more than 20% in the past year.

CEO

Badree Komandur (53 yo)

1.4yrs
Tenure
₹58,100,000
Compensation

Mr. Badree Komandur had been the Chief Financial Officer and Executive Director of Finance of Strides Pharma Science Limited (formerly known as Strides Shasun Limited) since August 1, 2013 until June 1, 20...

Leadership Team

NamePositionTenureCompensationOwnership
Arun Pillai
Founder & Non-Executive Chairperson35.4yrs₹90.00m2.24%
₹ 1.9b
Badree Komandur
MD & Group CEO1.4yrs₹58.10m0.060%
₹ 51.4m
Vikesh Kumar
Group CFO & Chief Investor Relations Officer1.4yrs₹39.93mno data
Manjula Ramamurthy
Compliance Officer & Company Secretary8.8yrs₹10.00mno data
Aditya Kumar
Executive Director of Business Development & Director1.4yrs₹16.20m0.063%
₹ 54.6m
P. V. Ramaraju
Chief Operating Officer1.7yrsno datano data
Sormistha Ghosh
Group General Counselno datano datano data
Surabhi Loshali
Group Chief Human Resource Officerno datano datano data
C. Sundar
Executive Vice President of Operationsno datano datano data
Kevin Cook
Senior Vice President of Strides Pharma Inc.no datano datano data
Umesh Kale
Chief Quality Officerno datano datano data
A. Narayanan
Chief Information Technology Officerno datano datano data
1.4yrs
Average Tenure
49yo
Average Age

Experienced Management: 532531's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Arun Pillai
Founder & Non-Executive Chairperson35.4yrs₹90.00m2.24%
₹ 1.9b
Badree Komandur
MD & Group CEO8.5yrs₹58.10m0.060%
₹ 51.4m
Aditya Kumar
Executive Director of Business Development & Director1.4yrs₹16.20m0.063%
₹ 54.6m
Homi Khusrokhan
Independent Director8.5yrs₹4.50mno data
Dennis Bastas
Executive Chairman of Arrow Pharmaceuticals Pty Ltdno datano datano data
Ameet Hariani
Independent Director1.8yrs₹800.00kno data
Gopakumar Nair
Member of Scientific Advisory Boardno datano datano data
Elias Neto
Member of Scientific Advisory Boardno datano datano data
S. Vyas
Member of Scientific Advisory Boardno datano datano data
B. Suresh
Member of Scientific Advisory Boardno datano datano data
C. Gupta
Member of Scientific Advisory Boardno datano datano data
Kausalya Santhanam
Independent Director5.9yrs₹4.75m0.0024%
₹ 2.1m
7.2yrs
Average Tenure
64.5yo
Average Age

Experienced Board: 532531's board of directors are considered experienced (7.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/02 02:51
End of Day Share Price 2025/10/31 00:00
Earnings2025/09/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Strides Pharma Science Limited is covered by 14 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Aditya KhemkaAmbit Capital
Harith AhamedAvendus Spark
Prakash AgarwalAxis Capital Limited